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Corticosteroid effects on isotonic contractile properties of rat 
diaphragm muscle. J . Appl. PhysioL 83(4): 1062-1067,1997.— 
The effects of corticosteroids (CS) on diaphragm muscle 
(Diam) fiber morphology and contractile properties were 
evaluated in three groups of rats: controls (Ctl), surgical 
sham and weight-matched controls (Sham), and CS-treated 
(6 mg-kg”11 day“1.prednisolone at 2.5 ml/h for 3 wk). In the 
CS-treated Diam, there was a selective atrophy of type IIx and 
lib fibers, compared with a generalized atrophy of all fibers in 
the Sham group. Maximum isometric force was reduced by 
20% in the CS group compared with both Ctl and Sham, 
Maximum shortening velocity in the CS Diam was slowed by 
^20% compared with Ctl and Sham. Peak power output of the 
CS Diam was only 60% of Ctl and 70% of Sham. Endurance to 
repeated isotonic contractions improved in the CS-treated 
Diam compared with Ctl. We conclude that the atrophy of type 
IIx and lib fibers in the Diam can only partially account for the 
CS-induced changes in isotonic contractile properties. Other 
factors such as reduced myofibrillar density or altered cross­
bridge cycling kinetics are also likely to contribute to the 
effects of CS treatment.
prednisolone; skeletal muscle; fiber type; shortening velocity; 
fatigue; endurance
CORTICOSTEROID (CS) trea tm ent is common in the clini­
cal setting, despite a variety of contraindications, includ­
ing skeletal muscle myopathy. Recently, considerable 
attention has focused on the possibility th a t  CS trea t­
m ent impairs diaphragm muscle (Diam) function in 
patients with chronic obstructive pulmonary disease 
(1). In these patients, CS treatm ent appears to contrib­
ute to Diam weakness, further reducing the ir functional 
reserve capacity. To date, animal studies have exam­
ined only the effects of CS trea tm ent on isometric 
properties of the Diam. However, an  examination of only 
the isometric properties of the Diam may not reveal the 
true  impact of CS treatm ent. The force-velocity relation­
ship is an essential characteristic of Diam contractile 
properties, and, to date, there is very little information 
concerning the effects of CS treatm ent on the ability of 
the  Diam to shorten. This may explain the equivocal 
results of animal studies reporting either no effect of CS 
trea tm en t on maximum isometric specific force (P0; 
force normalized for muscle cross-sectional area) of the 
Diam (2, 3, 10, 13, 22) or only a small reduction in 
specific force (20).
As in other skeletal muscles, the maximum shorten­
ing velocity (V*TOax) ° f  Diam fibers displays a strong 
association with myosin heavy chain (MHC) isoform
composition (8, 18). In  the Diam, type IIx and l ib  fibers, 
expressing th e  MHC2x and MHC2b isoforms, respec­
tively (16, 19), have a  faster Vmax than  type I and Ha 
fibers, expressing the  MHCsi0W and MHC2a isoforms, 
respectively. An effect of CS trea tm ent on th e  force- 
velocity relationship of the Diam is suggested by the 
selective atrophy of type IIx and/or lib  fibers (2, 3,12,
14, 20, 22). Accordingly, we hypothesize th a t,  in the
Diam, CS trea tm en t is associated with a slowing ofVmax.
Fiber type differences in Vmax also correspond to 
differences in  power output, with type IIx and l ib  fibers 
generating g reater power than  type I and H a fibers (18, 
19). If CS trea tm en t selectively affects the size of type 
IIx and lib fibers, th en  the power output of the  Diam 
should be reduced. The increased power ou tpu t of type 
IIx and lib D iam fibers is also associated w ith  greater 
energetic demands, compared with type I and H a fibers 
(18). Thus a  reduction in the relative contribution of 
type IIx and l ib  fibers to total Diam mass should result 
in an overall reduction in energy requirements. If 
muscle fatigue is re la ted  to an imbalance between 
energy supply and energy demand, the  effects of CS 
treatm ent m ay be reflected by an improvement in 
fatigue resistance (ra te  of force decline) or endurance 
(duration of sustained  power output). Indeed, previous 
studies have reported an  improvement in isometric 
fatigue resistance of the  ra t  Diam after CS treatm ent 
(13, 22). However, since energy requirem ents increase 
with power output (4, 18), the effects of CS treatm ent 
on improving endurance should be even more pro­
nounced during repetitive isotonic shortening.
In the present study, we evaluated the effects of CS 
treatm ent on the isotonic contractile and  endurance 
properties of the r a t  D iam. We hypothesized th a t  CS 
treatm ent induces a  selective atrophy of type IIx and 
lib  Diam fibers and th a t, as a result, there is a  slowing 
of Vmax> a decrease in  power output, and an improve­
ment in isotonic endurance.
METHODS
Male Sprague-Dawley rats (initial body weights 315 ± 5 g) 
were divided into three groups: 1) untreated controls (Ctl; n = 
8); 2) surgical sham and weight-matched controls (Sham; n -  
8); and 3) CS-treated (CS; n = 8). All animals were housed in 
separate cages under a 12:12-h light-dark cycle, fed with 
Purina rat chow, and provided with water ad libitum. Ani­
mals in the Ctl and CS groups were provided food ad libitum» 
whereas rats in the Sham group were food restricted to match 
their weight growth curve with that of the CS group. Body 
weights were monitored daily in all groups.
All procedures used in this study were approved by the 
Institutional Animal Care and Use Committee of the Mayo
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Clinic and were in strict accordance with the American 
Physiological Society animal care guidelines. Surgical proce­
dures were performed under aseptic conditions. The recovery 
of animals from surgery was carefully monitored.
CS treatment. Animals were anesthetized by the adminis­
tration of ketamine (60 mg/kg im) and xylazine (2.5 mg/kg 
im), and a miniosmotic pump (Alzet 2M4) was implanted 
sucutaneously in the neck. In the CS group, the miniosmotic 
pump contained a 37.5 mg/ml aqueous suspension of predniso­
lone sodium succinate (Upjohn), whereas in the Sham group 
the pump contained a sterile physiological saline solution. 
Based on a flow rate of 2.5 ¡A/h. for the osmotic pump, a dose of 
6 mg/kg prednisolone was provided continuously for a 3-wk 
period. Measurements of the remaining amount of solution in 
the pump at the end of the 3-wk treatment period were used 
to estimate total drug delivery. At the terminal experiment, 
blood samples were obtained to measure prednisolone, 3,3',5- 
triiodo-L-thyronine (T3), and thyroxine (T*).
Fiber type composition and morphology. After the 3-wk 
treatment period, the rats were anesthetized with pentobarbi­
tal sodium (70 mg/kg), and the right Diam was rapidly excised. 
Muscle segments were dissected from the midcostal region, 
and the resting excised length of the strip was measured by 
using digital calipers. The muscle strips were then stretched 
to 1.5 times this excised length [an approximation for optimal 
fiber length (L0) (15)], pinned on cork, and rapidly frozen in 
melting isopentane cooled to its melting point by liquid 
nitrogen.
Transverse sections of muscle fibers were cut at 6 jim by 
using a cryostat (Reichert Jung 2000E) kept at -20°C. The 
muscle sections were then reacted with antibodies to different 
MHC isoforms: 1) mouse anti-MHCs]0W immunoglobulin (Ig) 
G (Novocastra) for identification of type I fibers by positive 
immunoreactivity; 2) mouse anti-MHC2A IgC (7) for identifi­
cation of type Ha fibers by positive immunore activity; 3) 
mouse anti~MHCaii-2X IgG (16) f°r identification of type IIx 
fibers by negative immunore activity; and 4) mouse anti- 
MHC2b IgM (16) for identification of type lib fibers by positive 
immunore activity. After a 2- to 3-h incubation with the 
primary antibody, the sections were washed in 0,1 M phos­
phate buffer and incubated further in Cy3-conjugated donkey 
anti-mouse IgG or IgM.
The fluorescently stained sections were visualized by using 
an Olympus BH-2 microscope. Images of the stained muscle 
sections were digitized into a 1,024 X 1,024 array of picture 
elements (pixels) by using a charge-coupled diode camera 
attached to a calibrated image-processing system (19). With 
the use of a X20 microscope objective, each pixel had a 
projected area of 0.15 jim2. The cross-sectional area of indi­
vidual muscle fibers was determined from the number of 
pixels within the delineated boundary of the fiber. To deter­
mine fiber type proportions, ~500 muscle fibers were sampled 
from each Diam. Cross-sectional areas were measured for at 
least 25 fibers of each type within a given muscle. The relative 
contribution of each fiber type to the total area of the muscle 
segment (an estimate of total mass when L0 was similar) was 
calculated based on the proportion and average cross- 
sectional area of each fiber type.
MHC isoform composition. The techniques for determina­
tion of MHC isoform composition of the rat Diam have been 
previously described (8, 19). Briefly, myosin was extracted 
from scissor-minced Diam tissue, the extracts were centri­
fuged, and supernatants were recovered. After overnight 
storage to allow precipitation of myosin filaments, the solu­
tion was centrifuged, and the pellet was dissolved in a sample 
buffer, boiled, and then stored frozen. Different MHC isoforms 
were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis. The identity of specific MHC bands in silver- 
stained gels had been previously determined by using immu- 
noblotting techniques (9, 19). The relative composition of the 
different MHC isoforms was determined by densitometry, 
normalizing the average density of each band for the total 
peak densities for all the isoforms combined.
Contractile and endurance properties. Muscle strips (~3 
mm wide) were dissected from the midcostal region, with 
fiber insertions at the costal margin and central tendon left 
intact. The muscle strip was mounted vertically in a glass 
tissue chamber containing oxygenated mammalian Ringer 
solution of the following composition (mM): 135 Na+, 5 K+, 2 
Ca2+, 1 Mg24", 121 CI“, 25 HCOg, 11 glucose, 0.3 glutamic 
acid, 0.4 glutamate, andN tN-his(2-hydroxyethyl)-2-aminoeth­
ane-sulfonic acid buffer (pH = 7.4). A 0.0008% solution of 
d-tubocurarine chloride was added to prevent neuromuscular 
transmission. The solution was oxygenated with 95% 0 2-5% 
CO 2 and maintained at 26°C. The origin of the muscle bundle 
along the costal margin was attached to a metal clamp 
mounted in series with a micromanipulator at the base of the 
tissue chamber. The central tendon was glued to a thin, stiff 
plastic rod that was firmly fixed to the lever arm of a 
dual-mode length-force servo-control system (Cambridge Tech­
nologies, model 300B).
The muscle was stimulated directly by using platinum 
plate electrodes placed in close apposition on either side of the 
muscle. Rectangular current pulses (0,5-ms duration) were 
generated by using a Grass S88 stimulator and amplified by a 
current amplifier (Mayo Foundation, Section of Engineering). 
The stimulus intensity producing the maximum twitch force 
response was determined, and the stimulus intensity was set 
at —125% of this value for the remainder of the experiment 
(—220 mA). Muscle preload was adjusted by using the micro- 
manipulator until L 0 for maximal twitch forcé was achieved.
The Cambridge system was controlled by using custom- 
built software (LabView), implemented on an IBM 486 per­
sonal computer. Length and force were independently con­
trolled, allowing the Cambridge system to operate either in 
isometric or isotonic modes, respectively. Length and force 
outputs were digitized by using a data-acquisition board 
(National Instruments) at a sampling frequency of 1 kHz.
Peak isometric twitch force (Pt) and P0 (600-ms duration 
train) were measured. The force-velocity relationship of the 
Diam was then determined. While the muscle was maximally 
stimulated at 75 Hz for 330 ms, afterloads were clamped at 
values ranging from 3 to 100% of P0. A shorter stimulus 
duration was used to accommodate the limited range of lever 
movement of the Cambridge system during muscle shorten­
ing. At least 1 min intervened between each load level. The 
velocity of shortening at each load clamp was calculated as 
the change in muscle length (normalized for L 0) during a 
50-ms period. To eliminate the dynamics of connective and 
other noncontractile tissue in the muscle, the time window for 
this measurement was set to begin at 25 ms after the first 
detectable change in length. Vmax was calculated by fitting the 
force-velocity curve by using the modified Hill equation and 
extrapolating the fitted curve to zero-load (21).
Power output during isotonic contraction was calculated as 
the product of force and velocity, and the load clamp level 
yielding maximum power was determined. The load clamp 
was set to this value, and endurance was assessed during 
repetitive isotonic shortening induced by stimulating the 
muscle at 75 Hz in 330-ms duration trains repeated every 
second. The time at which power output declined to zero (no 
detectable muscle shortening) was defined as endurance time.
After the experiment, the muscle was weighed, and cross- 
sectional area was estimated based on the following formula:
CORTICOSTEROIDS AND DIAPHRAGM MUSCLE
muscle weight (g)/[L0 (cm)-1.056 (g/cm3)]. Forces were then
normalized for cross-sectional area of the muscle segments.
Statistical analysis. Data were compared by using a one­
way analysis of variance followed by Duncan’s multiple-range 
test. RepWted-measures analysis of variance was used for 
analysis of force-frequency, force-velocity, and force-power 
relationships, as well as for the analysis of the decline in 
maximum power output during the isotonic fatigue test. 
Statistical significance was tested at the 0.05 level. All data  
were expressed as means ± SE.
RESULTS
Efficacy of CS treatment. After 3 wk of treatment, 
there was very little residual solution (<5% of total 
volume) remaining in the miniosmotic pumps. Predniso­
lone levels measured in blood serum of Ctl and Sham 
animals were below detectable levels (<0.5 /¿g/dl). In 
contrast, the serum prednisolone level measured in the 
CS-treated animals at the time of the terminal experi­
ment was 4.9 ± 1 pg/dl. Serum T3 and T4 levels were not 
significantly different across the three experimental
groups (Ctl: T3 46 ± 3 ng/dl, T4 4.0 ± 0.2 jxg!dl; Sham: T3 
48 ± 6 ng/dl, T4 4.2 ± 0.4 /¿g/dl; and CS: T3 47 ± 4 ng/dl,
T4 3.9 ± 0.4 /¿g/dl).
Body weights, Over the 3-wk experimental period, 
body weights of Ctl animals increased by 26% (315 ± 7 
g initial and 397 ± 9 g final body weights). In the CS 
and Sham animals, body weight gain was significantly 
reduced compared with Ctl (P < 0.05), increasing by 
only 6 and 4%, respectively (CS: 319 ± 5 g initial and 
338 ± 9 g final body weights; Sham: 313 ± 7 g initial 
and 327 ± 9 g final body weights).
Fiber type composition and morphology. In all three 
experimental groups, fiber types could be readily classi­
fied by immunoreactivity for the different MHC antibod­
ies. The incidence of coexpression of MHC isoforms 
appeared to be very low (<1%) in all three groups. 
However, it was not possible to detect coexpression of 
MHC2x and MHC2B isoforms by immunohistochemis- 
try, and it is likely that such coexpression was more 
frequent (19). There were no differences across groups 
in the proportions of different fiber types (Table 1).
In the CS-treated animals, cross-sectional areas of
type IIx and lib Diam fibers were significantly smaller
than  those of type IIx and lib fibers in Ctl (P <  0.05;
Table 1). In contrast, cross-sectional areas of type I and
Ila  fibers in the CS Diam were comparable to similar
fiber types in Ctl animals. In the Sham Diam, there was
a generalized atrophy of all fiber types compared with
Ctl (P < 0.05; Table 1). Type I fibers in the Sham Diam
were also smaller than type I fibers in the CS Diam (P <
0.05; Table 1). Cross-sectional areas of type Ila, IIx, and
Hb fibers in the CS Diam were comparable to similar 
fiber types in Sham animals.
In the CS Diam, the relative contribution of type I 
fibers to total Diam cross-sectional area increased (P < 
0.05, Table 1). Otherwise, there were no differences 
across groups in the relative contribution of different 
fiber types to total Diam cross-sectional area. However, 
the combined contribution of type IIx and lib fiber 
areas was —60% of total Diam cross-sectional area in
Table 1- Effect o fCS treatment on fiber type
proportions, cross-sectional areas} and relative
contributions to total D iam cross-sectional area
Treatment Type I Type Ila Type IIx Type l i b
Fiber type proportions, %total
Ctl 36.1 + 0.5 32.5 + 0.7 23.5 ± 1 .5
Sham  37.4 ±1.5 31.0 ±1.2  24.1 ± 1 .5
CS 40.4 ±  2.2 29.9 + 1.5 24.1 ± 1 .9
Fiber cross-sectional area, pm2
Ctl 875 ±28 821 ±35  2,666 ± 1 6 3
Sham  600 ±19* 693 ±18* 1,710 ± 7 5 *
CS 772±62t 770 ± 67f 1,668 +  202* 2,284 J z . i u i -
Relative contribution to total Diam area, %total
Ctl 21.7±0.9 18.6 + 0.6 44 .2± 4 .1  1 5 .5 ± 3 .H
Sh am  21.6 + 1.6 20.6 + 2.0 39.5 ± 3 .3  19.2 +  4 .1
CS 29.8±2.3*t 21.7 ±1.4  37 .2± 3 .2  11.3 +  3-1__mugr.  ^ •
V alues are means ± SE. Ctl, control group; Sham , Sham  g r o u p ;   ^
corticosteroid-treated group; Diam, diaphragm muscle. sf,P  <  O.vhi 
com pared with Ctl group. | P  <  0.05 compared w ith  S h am  g ro u p .
Ctl a n d  Sham animals b u t only —48% in  th e  C S g r o u p  
(Table 1).
M H C  isoform composition. On the basis  of e le c t r o p h o -  
retie separation, the relative expression of th e  a
isoform decreased in the  CS-treated D ia^  (P <  0 . 0 5 ;  
Table 2). The MHC isoform composition of C tl a n d  
S ham  Diam was comparable (Table 2).
Contractile and endurance properties* A fter 3 w k  o f 
CS trea tm en t, Pt and P 0 of the D iam w ere r e d u c e d  
com pared with both C tl and Sham  groups (P <  G.OfS, 
Table 3). Pt and P0 were not different betw een  C tl  a n d  
Sham  animals. Compared with Ctl and  S h am  g r o u p s ,  
the force-velocity relationships of th e  CS D iam w o rt*  
sh ifted  to the left (P <  0.05; Fig. 1A). The Vmax of t h e  C H  
Diam w as significantly slower than  th a t  of both  C tl  a n d  
Sham  Diam (P <  0.05, Fig. IB). In all D iam, p e a k  p o w e r  
o u tp u t occurred a t 33% of P0 and a t 33% o f V milx ( F i g \  
2). P e a k  power output of the CS Diara w as s ig n i f ic a n t ly  
lower th an  th a t of both Ctl and Sham  groups (F ig .  2 ;  
P  <  0.05). The peak power output of th e  S h am  D ia m w a s  
also slightly lower th an  th a t  of Ctl an im als  (Fig. 2; P  * 
0.05).
W ith  repetitive shortening contractions, m a x i m u n i  
power output of the Diam rapidly declined in  a ll t h r o e  
groups (Fig. 3; P  <  0.05), After 60 s of r e p e t i t i v e  
contractions, Diam power output was com parab le  in  a l l  
th ree groups (Fig. 3). However, given th e  d iffe rences  i n  
the in it ia l  peak power ou tpu t of each group, th e  r a t e  o f  
decline in power was slower in the CS D iam c o m p a r e d  
with bo th  Sham and Ctl animals (Fig. 3; P  <  0 .0 5 ) .
Treatment MHCh1ow MHC2A MHC2X
I I ________________^  ______________  ___ _______ ______________  ____ __  ^ ______  ^  ^ i
Ctl 22.5 ±1.1 29.0 ±1.2 34.1 ±1.2 14.5 ±  3 9
Sham 24.0 ±2.3 30.2 ± 1.8 31.6 ± 2.0 14 2 ± 2 1  
CS 25.3 ±1.9 34.8 ±1.5 33.4 ± 1,0
Values are means ± SE. MHC, myosin heavy chain. :|iP  <  n  n r  
compared with Ctl, fp  < 0.05 compared with Sham group. " * *
6.8 ±
7 .5  ±




3 ,3 8 8  ± 2 6 8
2 ,6 8 5  ±3_- . AArtrfi
Table 2, Effect o fCS treatment on MHC isoform  
composition ofDiam (%total MHC)
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Table 3. Effect ofCS treatment on isometric contractile 
p7'op@7’ti>@s o f the Diam
Treatment Pt, N/cm2 P0, N/cm2 p/p.
Ctl 10.5 ±0.7 21.1 ± 1.5 0.50 ± 0.02
Sham 11.4 ±0.7 20.3 ± 1.0 0.56 ± 0.02
CS 7,4 ±0,6f 16.6 ±0.9*+ 0.44 ± 0.02*t
Values are means ± SE. Pt, peak twitch force; P0, maximum tetanic 
force. *P < 0.05 compared with Ctl; t P < 0.05 compared with Sham
group.
Endurance time of the CS Diam was 120 ± 6 s compared 
with 96 ± 4 s for Ctl (P < 0.05) and 108 ± 7 s for Sham 
(Fig. 3).
DISCUSSION
The results of the present study support our hypoth­
eses th a t CS treatm ent induces a selective atrophy of 
type IIx and lib  fibers in the ra t Diam, which is 
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Pig. 1 . A: force-velocity relationships of corticosteroid-treated (CS) 
diaphragm muscle (Diam) were shifted leftward compared with both 
control (Ctl) and surgical sham and weight-matched controls (Sham) 
animals tP < 0.05). B : maximum shortening velocity (Vmax) was 
slower in CS Diam compared with both Ctl and Sham groups (P < 
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Fig. 2. Power output at each load was reduced in CS and Sham 
groups compared with Ctl (P < 0.05). In addition, power output of CS 
Diam group was less than that of the Sham group (P < 0.05). Peak 
power output occurred at —33% maximum tetanic force in each group 
and was reduced in CS and Sham groups compared with Ctl (P < 
0.05). Peak power output of CS Diam group was also lower than that 
of Sham rats (P < 0.05),
output, and an improvement in isotonic endurance. 
However, the CS-induced changes in Diam isotonic 
properties were disproportionately greater than  the 
changes in type IIx and lib fiber morphology and MHC 
isoform expression. Therefore, we conclude that, in 
addition to the selective atrophy of type IIx and lib  
fibers, CS treatment exerts an influence on cross-bridge 
cycling kinetics.
Across the 3-wk period, the normal increase in body 
weight observed in Ctl rats was blunted by CS tre a t­
ment. The final body weight of the CS-treated animals 
was ~15% lower than that of Ctl rats. Because alter­
ations in nutritional status alone can affect morphology 
and function of the ra t Diam (2,11,17), in terpretation of 
the direct effects of CS treatm ent is confounded. How­
ever, the morphological and contractile adaptations of 
the Diam in the Sham group, where body weight was 
matched to that of the CS group by food restriction, 
were generally dissimilar to those observed in the 
CS-treated animals. These results suggest th a t  the 
effects of CS treatment on Diam structural and func­
tional properties cannot be solely attributed to a nonse- 
lective catabolic effect.
The CS-induced selective atrophy of type llx  and lib  
Diam fibers observed in the present study is in general 
agreement with several previous studies (2, 3, 12, 14, 
20, 22). However, these previous studies did not classify 
fiber types based on expression of different MHC iso-
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Fig. 3. During repetitive isotonic shortening at 30% maximum 
tetanic force, power output of the Diam rapidly declined in all 3 groups 
(P < 0.05). Rate of decline of power was slower in CS Diam compared 
with Ctl and Sham groups (P < 0.05). Endurance time of CS Diam 
group was prolonged compared with Ctl group (P <0.05) but was not 
significantly different from Sham group.
form, nor did they distinguish between type IIx and lib 
fibers. Standard histochemical classification of fiber 
types based on the pH lability of myofibrillar adenosine- 
triphosphatase (ATPase) staining, as used in these 
studies, cannot distinguish type IIx fibers, which are 
abundant in the rat Diam (9, 19). In addition, the 
MHC2b isoform is often coexpressed with the MHC2x 
isoform. Therefore, it is not surprising that type IIx and 
lib fibers displayed a similar pattern of atrophy in 
response to CS treatment. In the Sham Diam, there was 
a generalized atrophy of all fiber types, which has also 
been previously observed (2, 10, 11, 17, 20, 22). When 
combined, type IIx and lib fibers comprised ~60% of 
both Ctl and Sham Diam but only —48% of the CS Diam. 
In the CS-treated Diam, there was a reduction in the 
relative expression of the MHC2b isoform, whereas no 
changes in MHC isoform expression were observed in 
the Sham group. When combined, MHC2x and MHC2B 
isoforms comprised ~-40% of the CS Diam compared 
with —49% of Ctl and —46% of Sham Diam. The 
relatively modest change in MHC isoform composition 
of the CS Diam was consistent with the normal T3 and 
T4 levels of these animals. Clearly, the CS-induced 
morphological adaptations of type IIx and lib Diam 
fibers and the alterations in MHC isoform expression 
were not as pronounced as the changes in isotonic 
contractile properties.
Three weeks of CS treatment resulted in a 20% 
reduction in Pa compared with both Ctl and Sham 
groups. These results are in agreement with the previ­
ous report of van Balkom et al. (20) but contrast with 
several other studies in which no effect of CS treatment
1
on Dia^ P0 was observed (2, 3 ,10, 13, 22). The reasons
for these discrepant results are unclear but may relate 
to the type, dose, and duration of CS treatment used. It 
is unlikely that the reduction in specific force of the 
CS-treated Diam observed in the present study was 
attributable only to the selective atrophy of type IIx 
and lib fibers or the reduction in MHC2b isoform 
expression. A reduction in specific force could also arise 
from a number of alternative mechanisms, including a 
decrease in myofibrillar density and/or changes in 
cross-bridge cycling kinetics. Lieu and colleagues (12) 
reported that CS treatment is associated with a reduc­
tion of myofibrillar and sarcoplasmic protein concentra­
tion in the rat Diam, albeit not as pronounced as in the 
plantaris muscle. Such alterations in myofibrillar and 
sarcoplasmic protein concentration could reflect a de­
crease in the number of available cross bridges and/or 
changes in calcium handling.
The force-velocity relationship of the Diam was al­
tered by CS treatment such that Vmax was slowed by 
~20% and peak power output was reduced by 40% 
compared with Ctl animals. The slowing of Vmax in the 
CS Diam is generally consistent with the selective 
atrophy of type IIx and lib fibers and the reduction in 
MHC2b expression. However, the slowing of Vmax in­
duced by CS treatment was substantially greater than 
that which would be predicted by the relatively modest 
reduction in MHC2b expression. Therefore, it is un­
likely that the slowing of Vmax in the CS-treated Diam 
was solely attributable to a selective atrophy of type IIx 
and lib fibers and/or the reduction in MHC2B expres­
sion. In muscle fibers, Vmax is correlated with actomyo- 
sin ATPase activity (18) and cross-bridge cycling rate. 
Type I and Ha fibers have lower actomyosin ATPase 
activities than type IIx and lib fibers (18,19) and, as a 
result, a slower Vmax. It is possible that the slowing of 
Vmax in the CS-treated Diam reflects a decrease in 
actomyosin ATPase activity of muscle fibers indepen­
dent of MHC isoform expression.
In all groups, the Diam displayed very rapid fatigue 
during repetitive isotonic contractions at a load corre­
sponding to peak power output. During shortening 
contractions, muscle fiber energy utilization increases 
(4, 18); thus the rapid fatigue may be related to an 
imbalance between energy utilization and energy pro­
duction. CS-treated animals displayed a slower rate of 
power decrement during repetitive isotonic contrac­
tions compared with Ctl and Sham groups and pro­
longed endurance time compared with Ctl rats. These 
results are in general agreement with the improved 
fatigue resistance during repetitive isometric contrac­
tions noted in previous studies (13, 22). However, the 
results of the present study are in contrast to the report 
of Ferguson and colleagues (5), who found that CS- 
treated rabbits displayed less endurance to an incremen­
tal inspiratory threshold load. However, Diam fatigue 
was not directly verified in this study, and respiratory 
failure, used to define endurance, could have resulted 
from a number of mechanisms other than Diam fatigue.
The results of the present study suggest that CS 
treatment reduces energy utilization during repetitive 
isotonic contractions and thus improves the balance
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between energy supply and energy demand. A reduc­
tion in energy utilization would result from the selec­
tive atrophy of type IIx and lib fibers, which have 
higher actomyosin ATPase activities (18, 19). In addi­
tion, as suggested above, CS treatment may directly 
reduce actomyosin ATPase activity independent of MHC 
isoform expression. Other studies have also suggested 
that CS treatment impairs muscle energy utilization. 
For example, after CS treatment, there is an accumula­
tion of glycogen (5) and a reduction in creatine kinase 
activity (6). There may also be an effect of CS treatment 
on energy production. For example, it has been re­
ported that CS treatment reduces citrate synthase 
activity in the rat Diam (12, 20). However, no effect of 
CS treatment on succinate dehydrogenase activity was 
observed (10).
In conclusion, CS treatment causes a reduction in 
specific force, a slowing of Vmax, a decrease in power 
output, and an improvement in endurance during 
repetitive isotonic contractions. These contractile adap­
tations are generally consistent with the selective 
atrophy of type IIx and lib fibers and the reduction in 
MHC2b expression that was observed in the CS Diam. 
However, the contractile adaptations are disproportion­
ately greater than the morphological changes induced 
by CS treatment. Therefore, we conclude that the 
impairment of Diam function associated with CS treat­
ment involves additional mechanisms including a reduc­
tion in myofibrillar density and/or a slowing of cross­
bridge cycling kinetics.
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